Example: Heart Attack

Clinical Trials on Lupus Erythematosus, Cutaneous

Total 55 results

NCT04320680

Not yet recruiting

Systemic Lupus Erythematosus Within the Framework of the Multidisciplinary Consultation

Conditions: Systemic Lupus Erythematosus
NCT03958955

Terminated

Efficacy and Safety of Delgocitinib Cream in Discoid Lupus Erythematosus.

Conditions: Discoid Lupus Erythematosus
NCT03866317

Recruiting

A Study to Assess the Safety and Efficacy of Secukinumab in Alleviating Symptoms of Discoid Lupus Erythematosus

Conditions: Discoid Lupus Erythematosus
NCT03817424

Active, not recruiting

A Study to Evaluate VIB7734 in Participants With Systemic Lupus Erythematosus (SLE), Cutaneous Lupus Erythematosus (CLE), Sjogren's Syndrome, Systemic Sclerosis, Polymyositis, and Dermatomyositis

Conditions: Systemic Lupus Erythematosus; Cutaneous Lupus Erythematosus; Sjogren's Syndrome; Systemic Sclerosis; Polymyositis; Dermatomyositis
NCT03288324

Recruiting

Open-label Study of Tofacitinib for Moderate to Severe Skin Involvement in Young Adults With Lupus

Conditions: Cutaneous Lupus; Systemic Lupus Erythematosus
NCT03260166

Unknown status

Nicotinamide Treatment for Lupus-associated Skin Lesions in Lupus Erythematosus

Conditions: Cutaneous Lupus Erythematosus; Systemic Lupus Erythematosus Rash
NCT03178188

Unknown status

Efficacy of 595 nm Pulsed-dye Laser in Treatment of Discoid Lupus Erythematosus

Conditions: Lupus Erythematosus, Discoid
NCT03159936

Recruiting

Oral Tofacitinib in Adult Subjects With Discoid Lupus Erythematosus (DLE) and Systemic Lupus Erythematosus (SLE)

Conditions: Discoid Lupus Erythematosus; Systemic Lupus Erythematosus
NCT03134222

Completed

Study to Evaluate Safety and Efficacy of Filgotinib and Lanraplenib in Females With Moderately-to-Severely Active Cutaneous Lupus Erythematosus (CLE)

Conditions: Cutaneous Lupus Erythematosus
NCT03122431

Recruiting

Relevance of Monitoring Blood and Salivar Levels of Drugs Used in Rheumatic Autoimmune Diseases

Conditions: Systemic Lupus Erythematosus (SLE); Juvenile SLE; Cutaneous Lupus
NCT02927457

Completed

Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Clinical Effect of GSK2646264 in Cutaneous Lupus Erythematosus Subjects

Conditions: Lupus Erythematosus, Cutaneous
NCT02847598

Completed

Study to Evaluate BIIB059 in Cutaneous Lupus Erythematosus (CLE) With or Without Systemic Lupus Erythematosus (SLE)

Conditions: Systemic Lupus Erythematosus; Active Cutaneous Lupus Erythematosus
NCT02656082

Completed

Targeted Therapy Using Intradermal Injection of Etanercept for Remission Induction in Discoid Lupus Erythematosus

Conditions: Lupus Erythematosus, Discoid; Lupus Erythematosus, Cutaneous; Lupus Erythematosus, Chronic Cutaneous
NCT02428309

Terminated

Autologous Polyclonal Tregs for Lupus

Conditions: Lupus Erythematosus, Cutaneous; Lupus Erythematosus, Discoid; Lupus Erythematosus, Systemic
NCT02125695

Completed

Pilot Tape Harvesting Study

Conditions: Atopic Dermatitis; Healthy; Discoid Lupus Erythematosus; Subacute Cutaneous Lupus Erythematosus
NCT02034344

Completed

A Study of Skin and Systemic Biomarkers In Patients With Active Cutaneous Lupus Erythematosus And In Healthy Volunteers

Conditions: Lupus Erythematosus, Cutaneous; Lupus Erythematosus, Systemic; Lupus Erythematosus, Discoid; Healthy
NCT01923415

Completed

A Non-drug Study Profiling Cutaneous Lupus

Conditions: Lupus Erythematosus, Cutaneous; Lupus Erythematosus, Systemic; Lupus Erythematosus, Discoid
NCT01858792

Completed

A Pooled Analysis of the HGS1006-C1056 (BLISS-52) and HGS1006-C1057 (BLISS-76) Studies

Conditions: Lupus Erythematosus, Discoid
NCT01845740

Unknown status

Phase Ib Study of SC Milatuzumab in SLE

Conditions: Lupus Erythematosus, Cutaneous; Lupus Erythematosus, Discoid; Lupus Erythematosus, Systemic; Lupus Vasculitis, Central Nervous System; Lupus Nephritis
NCT01841619

Completed

IVIg Efficacy Study to Treat Cutaneous Lupus Erythematosus

Conditions: Cutaneous Lupus Erythematosus
NCT01776190

Recruiting

Low-dose UVA1 Radiation in Cutaneous Lupus Patients

Conditions: Cutaneous Lupus Erythematosus
NCT01702740

Completed

A Study of the Safety and Pharmacokinetics of CNTO 136 in Patients With Cutaneous Lupus Erythematosus and Systemic Lupus Erythematosus

Conditions: Lupus Erythematosus, Cutaneous; Lupus Erythematosus, Systemic
NCT01629784

Completed

Effectiveness of a Knowledge-based Intervention for Patients With Cutaneous Lupus Erythematosus

Conditions: Cutaneous Lupus Erythematosus
NCT01597050

Completed

Safety and Efficacy of Topical R333 in Patients With Discoid Lupus Erythematosus (DLE) and Systemic Lupus Erythematosus (SLE) Lesions

Conditions: Lupus Erythematosus, Discoid; Lupus Erythematosus, Systemic
NCT01559155

Terminated

Role of Proteasomes in a Dermatological Autoimmune Disease: Bullous Pemphigoid

Conditions: Pemphigoid, Bullous; Pemphigus; Lupus Erythematosus, Cutaneous
NCT01551069

Completed

Multicenter Study Assessing the Efficacy & Safety of Hydroxychloroquine Sulfate in Patients With Systemic Lupus Erythematosus or Cutaneous Lupus Erythematosus With Active Lupus Erythematosus Specific Skin Lesion

Conditions: Cutaneous Lupus Erythematosus-Systemic Lupus Erythematosus
NCT01516788

Completed

Photoprovocation Testing in Subjects With Cutaneous Lupus

Conditions: Lupus Erythematosus; Photosensitivity Conditions
NCT01510067

Recruiting

Prevalence and Clinical Severity of Cutaneous Lupus Erythematosus

Conditions: Cutaneous Lupus Erythematosus
NCT01498406

Terminated

Vitamin D Status, Disease Specific and Quality of Life Outcomes in Patients With Cutaneous Lupus

Conditions: Cutaneous Lupus Erythematosus
NCT01470313

Terminated

A Multiple Dose Study Of PD-0360324 In Patients With Active Cutaneous Lupus Erythematosus

Conditions: Cutaneous Lupus Erythematosus
NCT01466725

Terminated

A Research Study to Assess if CC-930 is Safe in Treating Subjects With Discoid Lupus Erythematosus

Conditions: Discoid Lupus
NCT01407679

Terminated

Efficacy and Safety of Oral Alitretinoin (Toctino®) in the Treatment of Patients With Cutaneous Lupus Erythematosus

Conditions: Lupus Erythematosus, Cutaneous
NCT01389895

Terminated

Safety Study of AMG 557 in Subjects With Subacute Cutaneous Lupus Erythematosus

Conditions: Cutaneous Lupus; Lupus
NCT01352988

Completed

Efficacy and Safety of Fumaric Acid Esters (Fumaderm®) in the Treatment of Patients With Cutaneous Lupus Erythematosus

Conditions: Lupus Erythematosus, Cutaneous
NCT01300208

Completed

To Evaluate the Preliminary Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of CC-11050 in Subjects With Discoid Lupus Erythematosus and Subacute Cutaneous Lupus Erythematosus

Conditions: Cutaneous Lupus Erythematosus
NCT01294774

Completed

Safety and Efficacy of KRP203 in Subacute Cutaneous Lupus Erythematosus

Conditions: Subacute Cutaneous Lupus Erythematosus
NCT01266915

Active, not recruiting

Cutaneous Lupus Registry

Conditions: Lupus Erythematosus
NCT01164917

Terminated

Safety Study of AMG 811 in Subjects With Discoid Lupus Erythematosus

Conditions: Cutaneous Lupus; Discoid Lupus; Lupus; Systemic Lupus Erythematosus
NCT01146444

Completed

Sunscreens in Patients With Cutaneous Lupus Erythematosus(CLE)

Conditions: Cutaneous Lupus Erythematosus
NCT00797784

Unknown status

The Safety and Efficacy of Etanercept (Enbrel®) for the Treatment of Discoid Lupus Erythematosus

Conditions: Discoid Lupus Erythematosus (DLE)
NCT00708916

Completed

Safety Study of Clinical and Immune Effects of Phosphodiesterase 4 (PDE-4) Inhibitor in Cutaneous Lupus Patients

Conditions: Discoid Lupus Erythematosus
NCT00691769

Completed

Expression of Fas Protein in Skin Biopsies of Participants With Scarring Alopecia

Conditions: Central Centrifugal Scarring Alopecia; Lichen Planopilaris; Discoid Lupus Erythematosus
NCT00633945

Completed

Evaluation of Lenalidomide (REVLIMID®) to Treat Subjects With Cutaneous Lupus Erythematosus (CLE)

Conditions: Cutaneous Lupus Erythematosus (CLE)
NCT00625157

Completed

Efficacy and Safety of ASF-1096 Cream 0.5% in the Treatment of Discoid Lupus Erythematosus (DLE) Lesions (2)

Conditions: Discoid Lupus Erythematosus
NCT00625521

Completed

Efficacy and Safety of ASF-1096 Cream 0.5% in the Treatment of Discoid Lupus Erythematosus (DLE) Lesions

Conditions: Discoid Lupus Erythematosus
NCT00608673

Completed

Comparing the Therapeutic Efficacy of Pimecrolimus Cream With Betamethasone Cream for Discoid Lupus Erythematosus

Conditions: Discoid Lupus Erythematosus
NCT00523588

Completed

Treatment of Cutaneous Lupus Erythematosus (CLE) With the 595 nm Flashlamp Pulsed Dye Laser

Conditions: Cutaneous Lupus Erythematosus
NCT00512694

Recruiting

Duke Lupus Registry

Conditions: Systemic Lupus Erythematosus; Cutaneous Lupus
NCT00470912

Completed

Sunscreen RV 2457C in Photoinduced CLE

Conditions: Cutaneous Lupus Erythematosus; Skin Lesion; Experimental Photoinduction; Protective Sunscreen
NCT00420121

Unknown status

European Society of Cutaneous Lupus Erythematosus (EUSCLE)

Conditions: Lupus Erythematosus, Cutaneous; Lupus Erythematosus, Systemic

Clinical Trials on Lupus Erythematosus, Cutaneous

Recent CRA jobs

Business Analyst (Salesforce)

Site Management Coordinator (Cape Town, Centurion or Bloemfontein based)

Dev Opns Engineer

Business Analyst - SaaS CRMs (Salesforce)

Centralized Monitoring Lead (Homebased)

Freelance- Translators/Linguists, Polish language

Jovem Aprendiz

Senior/Safety Specialist (Home/Office-Based) - IQVIA Biotech

Patient Pathway and Support Program Internship

Lead Contracts Analyst